anticancer program (AnHorn Medicines)

N/A

Report date: 2025/06/11 10:39:42
NME

Base Information

Drug Nameanticancer program (AnHorn Medicines)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnHorn Medicines Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnHorn Medicines Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A